Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site movement impairment, Vaccination site pain, Vaccination site swelling, Vaccination site warmth, Vomiting
Clinical narrative: Numbness in arm and hand of left arm (injection arm); Intense pain at injection site with swelling and heat; Intense pain at injection site with swelling and heat; Intense pain at injection site with swelling and heat; Chills; fever; Muscular pain throughout whole body; Intense Migraine & muscle spasms; Intense Migraine & muscle spasms; Nausea; vomiting; Insomnia; Inability to lift of move injection arm; administration date 04Sep2021(dose number 1) and administration date 24Oct2021 (for dose number 2); This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 24Oct2021 (Lot number: FF2590) at the age of 38 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Sjogren's Syndrome" (unspecified if ongoing), notes: Sjogren's Syndrome; "Hashimoto's Thyroid" (unspecified if ongoing), notes: Hashimoto's Thyroid; "Migraines" (unspecified if ongoing), notes: Migraines; "IBS" (unspecified if ongoing), notes: Irritable bowel syndrome; "Rheumatoid Arthritis" (unspecified if ongoing), notes: Rheumatoid Arthritis; "Known allergies: Yes" (unspecified if ongoing), notes: Allergies. The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: FC3184, Location of injection:  Left Arm), administration date: 04Sep2021, when the patient was 38 years old, for COVID-19 Immunization. The following information was reported: HYPOAESTHESIA (non-serious) with onset 24Oct2021, outcome "not recovered", described as "Numbness in arm and hand of left arm (injection arm)"; VACCINATION SITE PAIN (non-serious), VACCINATION SITE SWELLING (non-serious), VACCINATION SITE WARMTH (non-serious) all with onset 24Oct2021, outcome "not recovered" and all described as "Intense pain at injection site with swelling and heat"; CHILLS (non-serious) with onset 24Oct2021, outcome "not recovered", described as "Chills"; PYREXIA (non-serious) with onset 24Oct2021, outcome "not recovered", described as "fever"; MYALGIA (non-serious) with onset 24Oct2021, outcome "not recovered", described as "Muscular pain throughout whole body"; MIGRAINE (non-serious), MUSCLE SPASMS (non-serious) all with onset 24Oct2021, outcome "not recovered" and all described as "Intense Migraine & muscle spasms"; NAUSEA (non-serious) with onset 24Oct2021, outcome "not recovered", described as "Nausea"; VOMITING (non-serious) with onset 24Oct2021, outcome "not recovered", described as "vomiting"; INSOMNIA (non-serious) with onset 24Oct2021, outcome "not recovered", described as "Insomnia"; VACCINATION SITE MOVEMENT IMPAIRMENT (non-serious) with onset 24Oct2021, outcome "not recovered", described as "Inability to lift of move injection arm"; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 24Oct2021, outcome "unknown", described as "administration date 04Sep2021(dose number 1) and administration date 24Oct2021 (for dose number 2)". The events "numbness in arm and hand of left arm (injection arm)", "intense pain at injection site with swelling and heat", "intense pain at injection site with swelling and heat", "intense pain at injection site with swelling and heat", "chills", "fever", "muscular pain throughout whole body", "intense migraine & muscle spasms", "intense migraine & muscle spasms", "nausea", "vomiting", "insomnia" and "inability to lift of move injection arm" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of hypoaesthesia, vaccination site pain, vaccination site swelling, vaccination site warmth, chills, pyrexia, myalgia, migraine, muscle spasms, nausea, vomiting, insomnia, vaccination site movement impairment. Additional information: Treatment with tylonel, rest, heat, fluids, re-evaluate was given. Prior to vaccination, patient was not diagnosed with COVID-19.  No follow-up attempts are possible. No further information is expected.